Our approved medicines
The medicines listed below have marketing authorizations in the jurisdictions listed, but may not be reimbursed or available through a specific country’s health care system. For more information, please contact Medical Information.
Trademark |
Generic Name |
Therapy Area |
Approved in the Following Countries |
|
CASGEVY™ |
exagamglogene autotemcel (exa-cel) |
Sickle Cell Disease |
England |
|
CASGEVY™ |
exagamglogene autotemcel (exa-cel) |
Transfusion-Dependent Beta Thalasssemia |
England |
|
TRIKAFTA® |
elexacaftor/tezacaftor/ivacaftor and ivacaftor |
Cystic Fibrosis |
Australia |
|
KAFTRIO® |
ivacaftor/tezacaftor/elexacaftor in combination with ivacaftor |
Cystic Fibrosis |
European Union |
|
SYMDEKO® |
tezacaftor/ivacaftor and ivacaftor |
Cystic Fibrosis |
Australia |
|
SYMKEVI® |
tezacaftor/ivacaftor in combination with ivacaftor |
Cystic Fibrosis |
European Union |
|
ORKAMBI® |
lumacaftor/ivacaftor |
Cystic Fibrosis |
Australia |
|
KALYDECO® |
ivacaftor |
Cystic Fibrosis |
Australia |